Skip to content

Clinical trials

Phase 2 Hepatic Encephalopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Phase: Phase 2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20092
20141
20183
20191
20213
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hunter Holmes Mcguire Veteran Affairs Medical Center3
Amgen2
Ocera Therapeutics2
Axcella Health, Inc1
Genfit1
Mallinckrodt1
Massachusetts General Hospital1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Ocera Therapeutics, Inc.1
Ochsner Health System1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy17
Fibrosis8
Liver Cirrhosis5
Liver Diseases3
Brain Diseases2
Inflammation2
Liver Failure2
Acute-On-Chronic Liver Failure1
Cognitive Dysfunction1
End Stage Liver Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.